The UCLA Core Virology laboratory will provide laboratory support for the UCLA Pediatric ACTG effort. The laboratory is a well established unit that has been a """"""""certified"""""""" ACTG laboratory for cultures and antigen assays since the Quality Assurance (QA) program was established in 1987. The laboratory performed over 13,000 assays in the last calendar year. The faculty are members of the ACTG Virology Core committee and Pediatric Virology Subcommittee and have extensive experience in pediatric HIV diagnosis, monitoring and therapeutic interventions. The laboratory is currently an adult ACTG Core A1 laboratory. It is planned to expand and eventually transition the current adult laboratory into a fully functioning Core B1 Pediatric laboratory over the period of one year utilizing the senior skills of the current laboratory personnel and faculty to assure a smooth transition. This will result in an ACTG """"""""certified"""""""" pediatric laboratory with the capacity to provide HIV culture, resistance, DNA and RNA PCR assays, both p24 and Immune Complex Dissociated (ICD) p24 antigen assays as well as new assays in development.

Project Start
Project End
Budget Start
Budget End
Support Year
7
Fiscal Year
1994
Total Cost
Indirect Cost
Name
University of California Los Angeles
Department
Type
DUNS #
119132785
City
Los Angeles
State
CA
Country
United States
Zip Code
90095
Sha, Beverly E; Tierney, Camlin; Cohn, Susan E et al. (2011) Postpartum viral load rebound in HIV-1-infected women treated with highly active antiretroviral therapy: AIDS Clinical Trials Group Protocol A5150. HIV Clin Trials 12:9-23
Veloso, Valdiléa G; Bastos, Francisco I; Portela, Margareth Crisóstomo et al. (2010) HIV rapid testing as a key strategy for prevention of mother-to-child transmission in Brazil. Rev Saude Publica 44:803-11
Truong, Hong-Ha M; Sim, Myung S; Dillon, Maryanne et al. (2010) Correlation of immune activation during late pregnancy and early postpartum with increases in plasma HIV RNA, CD4/CD8 T cells, and serum activation markers. Clin Vaccine Immunol 17:2024-8
Aldrovandi, Grace M; Chu, Clara; Shearer, William T et al. (2009) Antiretroviral exposure and lymphocyte mtDNA content among uninfected infants of HIV-1-infected women. Pediatrics 124:e1189-97
Bryson, Y J; Mirochnick, M; Stek, A et al. (2008) Pharmacokinetics and safety of nelfinavir when used in combination with zidovudine and lamivudine in HIV-infected pregnant women: Pediatric AIDS Clinical Trials Group (PACTG) Protocol 353. HIV Clin Trials 9:115-25
Ching, Natascha; Yang, Otto O; Deville, Jaime G et al. (2007) Pediatric HIV-1-specific cytotoxic T-lymphocyte responses suggesting ongoing viral replication despite combination antiretroviral therapy. Pediatr Res 61:692-7
Fletcher, Courtney V; DeVille, Jaime G; Samson, Pearl M et al. (2007) Nonlinear pharmacokinetics of high-dose recombinant fusion protein CD4-IgG2 (PRO 542) observed in HIV-1-infected children. J Allergy Clin Immunol 119:747-50
Shearer, William T; DeVille, Jaime G; Samson, Pearl M et al. (2006) Susceptibility of pediatric HIV-1 isolates to recombinant CD4-IgG2 (PRO 542) and humanized mAb to the chemokine receptor CCR5 (PRO 140). J Allergy Clin Immunol 118:518-21
Lambert, John S; Moye Jr, Jack; Plaeger, Susan F et al. (2005) Association of selected phenotypic markers of lymphocyte activation and differentiation with perinatal human immunodeficiency virus transmission and infant infection. Clin Diagn Lab Immunol 12:622-31
Watts, D Heather; Lambert, John; Stiehm, E Richard et al. (2003) Progression of HIV disease among women following delivery. J Acquir Immune Defic Syndr 33:585-93

Showing the most recent 10 out of 44 publications